Letter: which risk factors for post-operative recurrence in Crohn's disease can be modified?

Anastomotic reinforcement in rectal surgery: a position statement from an expert panel of colorectal surgeons.

Updates in surgery·2026

The Emerging Role of Ultrasonography in Ulcerative Colitis.

Diagnostics (Basel, Switzerland)·2026

VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial.

Nutrients·2026

Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study.

Endoscopy international open·2026

Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study.

Journal of Crohn's & colitis·2026

Adiponectin and phase angle in the assessment of sarcopenia in Crohn's disease: beyond muscle mass.

Frontiers in nutrition·2026

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Alimentary pharmacology & therapeutics·2026

Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real-World Propensity Score-Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup.

Alimentary pharmacology & therapeutics·2026

Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study.

Alimentary pharmacology & therapeutics·2026

Treatment Patterns in Patients With Eosinophilic Oesophagitis Referred for Expert Consultation.

Alimentary pharmacology & therapeutics·2026

Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial.

Alimentary pharmacology & therapeutics·2026

Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Alimentary pharmacology & therapeutics·2026

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Neurological research·2026

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Endocrine-related cancer·2026

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Anesthesiology·2026

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Cancer cytopathology·2026

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Pakistan journal of pharmaceutical sciences·2026

Related Experiment Videos

Letter: which risk factors for post-operative recurrence in Crohn's disease can be modified?

Related Concept Videos

Anastomotic reinforcement in rectal surgery: a position statement from an expert panel of colorectal surgeons.

The Emerging Role of Ultrasonography in Ulcerative Colitis.

VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial.

Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study.

Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study.

Adiponectin and phase angle in the assessment of sarcopenia in Crohn's disease: beyond muscle mass.

Long-Term Major Adverse Liver Outcomes and Oncological Outcomes Across Steatotic Liver Disease Subtypes Classified Using the MetALD-ALD Prediction Index.

Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real-World Propensity Score-Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup.

Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study.

Treatment Patterns in Patients With Eosinophilic Oesophagitis Referred for Expert Consultation.

Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial.

Meta-Analysis: Enhanced Liver Fibrosis (ELF) Test for Identifying Significant Fibrosis, Advanced Fibrosis, and Cirrhosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Related Experiment Videos

Letter: which risk factors for post-operative recurrence in Crohn's disease can be modified?

Related Concept Videos

Related Articles